Healthcare >> CEO Interviews >> April 28, 2003
MICHAEL W. JACOBS is the Founder and Chairman of Pyng
Technologies Corp. and it's wholly owned subsidiary Pyng Medical
Corp. Mr. Jacobs has raised all the investment and venture
capital for Pyng's ventures since it's founding. He successfully
took Pyng on the Canadian venture Exchange (now the TSX Venture
Exchange out of Toronto) and onto the NASDAQ OTC Board. Mr.
Jacobs has worked closely with Dr. David Johnson, President, and
Judy Findlay, CEO, in the development and patents associated with
Intraosseous Infusion, which has culminated in the development of
the world's first FDA-approved Sternal Access Intraosseous
Infusion System. He has brought into the company in excess of
$5.5 million to support the research, development and
commercialization of the F.A.S.T.1 System to market. He has,
along with strong support from David Johnson and Judy Findlay,
devoted his energes over the last 12 years toward the commercial
success of the F.A.S.T.1 System and has been instrumental in
having the F.A.S.T.1 System adopted by the key emergency medical
distributors in America as well as successfully negotiated the
adoption of the F.A.S.T.1 System in the United States and
Canadian military. Profile
Mr. Jacobs: Pyng Technologies is a publicly traded corporation on
the Toronto Venture Exchange (PYT) and the NASDAQ Bulletin
